| TIM-3 restrains anti-tumour immunity by regulating inflammasome activation KO Dixon, M Tabaka, MA Schramm, S Xiao, R Tang, D Dionne, ... Nature 595 (7865), 101-106, 2021 | 287 | 2021 |
| Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis J Leipe, MA Schramm, M Grunke, M Baeuerle, C Dechant, AP Nigg, ... Annals of the rheumatic diseases 70 (8), 1453-1457, 2011 | 144 | 2011 |
| Fas promotes T helper 17 cell differentiation and inhibits T helper 1 cell development by binding and sequestering transcription factor STAT1 GM Zu Horste, D Przybylski, MA Schramm, C Wang, A Schnell, Y Lee, ... Immunity 48 (3), 556-569. e7, 2018 | 62 | 2018 |
| Increased Th17 Cell Frequency and Poor Clinical Outcome in Rheumatoid Arthritis Are Associated With a Genetic Variant in the IL4R Gene, rs1805010 J Leipe, MA Schramm, I Prots, H Schulze‐Koops, A Skapenko Arthritis & rheumatology 66 (5), 1165-1175, 2014 | 39 | 2014 |
| Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion C Zhu, KO Dixon, K Newcomer, G Gu, S Xiao, S Zaghouani, MA Schramm, ... Science Advances 7 (18), eabd2710, 2021 | 34 | 2021 |
| Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling M Pawlak, D DeTomaso, A Schnell, GM Zu Horste, Y Lee, J Nyman, ... Immunity 55 (9), 1663-1679. e6, 2022 | 28 | 2022 |
| The influence of long distance running on sonographic joint and tendon pathology: results from a prospective study with marathon runners F Proft, M Grunke, C Reindl, F Mueller, M Kriegmair, J Leipe, P Weinert, ... BMC musculoskeletal disorders 17, 1-8, 2016 | 24 | 2016 |
| COVID-19 in a severely immunosuppressed patient with life-threatening eosinophilic granulomatosis with polyangiitis MA Schramm, N Venhoff, D Wagner, J Thiel, D Huzly, N Craig-Mueller, ... Frontiers in Immunology 11, 2086, 2020 | 14 | 2020 |
| Identification of covariates modulating B‐cell repopulation kinetics in subjects receiving rituximab treatment T Welte, L Westermann, J Kappes, MA Schramm, X Bemtgen, ... Arthritis & Rheumatology 75 (11), 2045-2053, 2023 | 6 | 2023 |
| Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients N Venhoff, J Thiel, MA Schramm, I Jandova, RE Voll, C Glaser Frontiers in Immunology 11, 616992, 2021 | 5 | 2021 |
| NMDAR-Autoantikörper als Biomarker für Fatigue bei SLE MA Schramm, N Venhoff Zeitschrift für Rheumatologie 79 (1), 83-84, 2020 | 3 | 2020 |
| Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice N Talvard-Balland, LM Braun, KO Dixon, M Zwick, H Engel, A Hartmann, ... The Journal of Clinical Investigation 134 (16), 2024 | 2 | 2024 |
| Burden of disease and impact on quality of life in chronic back pain–a comparative cross-sectional study of 150 axial spondyloarthritis and 150 orthopedic back pain patients N Frede, S Hiestand, D Endres, LT van Elst, S Finzel, N Chevalier, ... Frontiers in medicine 10, 1221087, 2023 | 2 | 2023 |
| Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL-4R gene, rs1805010 J Leipe, M Schramm, I Prots, H Schulze-Koops, A Skapenko Annals of the rheumatic diseases, 146-147, 2014 | 2 | 2014 |
| Elevated expression of the Th17 cytokine interleukin 22 in rheumatoid arthritis M Schramm, J Leipe, H Schulze-Koops, A Skapenko Annals of the Rheumatic Diseases 69 (Suppl 2), A65-A66, 2010 | 1 | 2010 |
| Loss of lipid kinase pi5p4k gamma restricts tumor growth LC Cantley, VK Kuchroo, MA Schramm, KO Dixon US Patent App. 18/281,526, 2024 | | 2024 |
| Tim3 blockade in dendritic cells may potentiate antitumor immunity KO Dixon, M Tabaka, MA Schramm, S Xiao, R Tang, D Dionne Cancer Discovery 11 (8), 1873-1873, 2021 | | 2021 |
| Tumor Microenvironment KO Dixon, M Tabaka, MA Schramm, S Xiao, R Tang, D Dionne | | |
